therefore , binding of the calcium antagonist diltiazem was studied in protein solutions and in serum of healthy persons , patients with renal failure , patients with cirrhosis , patients with rheumatoid arthritis , patients with myocardial infarction , and intensive care patients .
C0012373
diltiazem
C0027051
myocardial infarction